Cell Growth & Differentiation, Vol 4, Issue 10 861-869, Copyright © 1993 by American Association of Cancer Research

ARTICLES

Functional interaction of wild-type and mutant p53 transfected into human tumor cell lines carrying activated ras genes

S Sharma, I Schwarte-Waldhoff, H Oberhuber and R Schafer
Department of Pathology, University of Zurich, Switzerland.

We have analyzed the antiproliferative activity of the p53 tumor suppressor gene in human tumor cell lines harboring activated ras genes. The levels of p53 protein and incorporation of bromodeoxyuridine in transiently transfected cells were determined simultaneously by flow cytometry. The human HT1080 fibrosarcoma, EJ bladder carcinoma, and SW480 colon carcinoma cell lines were equally sensitive toward wild-type p53-mediated inhibition of DNA synthesis, independent of the state of the endogenous p53 protein. Overexpression of p53 genes mutated at amino acid codon 143 resulted in increased proliferation of SW480 cells, which have two mutated endogenous p53 alleles. To mimic the genetic constitution of an evolving tumor cell that has sustained a mutation in one p53 allele, we coexpressed both wild-type and mutant p53 genes controlled by strong viral promoters in HT1080 cells. Transiently transfected cells showed a reduced bromodeoxyuridine uptake similar to cells into which only wild-type p53 had been introduced. The wild-type p53 gene is a dominant growth suppressor over the mutant in all three different cell lines analyzed. By immunoprecipitation with antibodies PAb 122, PAb 420, and PAb 1620, we demonstrate the presence of both the mutant and wild-type conformations of the p53 protein in the transfected cells.

This article has been cited by other articles:

				D. Olmeda, S. Castel, S. Vilaro, and A. Cano {beta}-Catenin Regulation during the Cell Cycle: Implications in G2/M and Apoptosis Mol. Biol. Cell, July 1, 2003; 14(7): 2844 - 2860. [Abstract] [Full Text] [PDF]

				T. Tan and G. Chu p53 Binds and Activates the Xeroderma Pigmentosum DDB2 Gene in Humans but Not Mice Mol. Cell. Biol., May 15, 2002; 22(10): 3247 - 3254. [Abstract] [Full Text] [PDF]

				K. Hashimoto, Y. Nakagawa, H. Morikawa, M. Niki, Y. Egashira, I. Hirata, K. Katsu, and Y. Akao Co-overexpression of DEAD box protein rck/p54 and c-myc protein in human colorectal adenomas and the relevance of their expression in cultured cell lines Carcinogenesis, December 1, 2001; 22(12): 1965 - 1970. [Abstract] [Full Text] [PDF]

				B. R. Dix, S. J. O’Carroll, C. J. Myers, S. J. Edwards, and A. W. Braithwaite Efficient Induction of Cell Death by Adenoviruses Requires Binding of E1B55k and p53 Cancer Res., May 1, 2000; 60(10): 2666 - 2672. [Abstract] [Full Text]

				L. Fang, S. W. Lee, and S. A. Aaronson Comparative Analysis of p73 and p53 Regulation and Effector Functions J. Cell Biol., November 15, 1999; 147(4): 823 - 830. [Abstract] [Full Text] [PDF]

				J. Fan and J. R. Bertino Modulation of Cisplatinum Cytotoxicity by p53: Effect of p53-Mediated Apoptosis and DNA Repair Mol. Pharmacol., November 1, 1999; 56(5): 966 - 972. [Abstract] [Full Text]

				O. V. Volpert, J. Lawler, and N. P. Bouck A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1 PNAS, May 26, 1998; 95(11): 6343 - 6348. [Abstract] [Full Text] [PDF]

				Z. Li, A. Yu, and A. M. Weiner Adenovirus Type 12-Induced Fragility of the Human RNU2 Locus Requires p53 Function J. Virol., May 1, 1998; 72(5): 4183 - 4191. [Abstract] [Full Text] [PDF]

				E. Benini, A. Costa, G. Abolafio, and R. Silvestrini p53 Expression in Human Carcinomas: Could Flow Cytometry Be an Alternative to Immunohistochemistry? J. Histochem. Cytochem., January 1, 1998; 46(1): 41 - 48. [Abstract] [Full Text]

				M. M. Sugrue, D. Y. Shin, S. W. Lee, and S. A. Aaronson Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53 PNAS, September 2, 1997; 94(18): 9648 - 9653. [Abstract] [Full Text] [PDF]